A good start: Antipsychotic drug maker to pay half billion in fines for illegal marketing
Drugmaker AstraZeneca has agreed to pay $520 million to settle federal investigations into marketing practices for its schizophrenia drug Seroquel. This makes AstraZeneca the fourth big drug company in the last three years to admit to federal charges of illegal marketing of antipsychotic drugs.
SHARE YOUR STORY/COMMENT: